Cargando…
439 Cystic fibrosis transmembrane conductance regulator impairment strongly decreases SARS-CoV-2 replication in human bronchial epithelial cells
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Cystic Fibrosis Society.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527880/ http://dx.doi.org/10.1016/S1569-1993(22)01129-8 |
| _version_ | 1784801171689439232 |
|---|---|
| author | Sorio, C. Lotti, V. Merigo, F. Lagni, A. Di Clemente, A. Ligozzi, M. Bernardi, P. Rossini, G. Concia, E. Plebani, R. Romano, M. Sbarbati, A. Gibellini, D. |
| author_facet | Sorio, C. Lotti, V. Merigo, F. Lagni, A. Di Clemente, A. Ligozzi, M. Bernardi, P. Rossini, G. Concia, E. Plebani, R. Romano, M. Sbarbati, A. Gibellini, D. |
| author_sort | Sorio, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9527880 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Cystic Fibrosis Society. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95278802022-10-03 439 Cystic fibrosis transmembrane conductance regulator impairment strongly decreases SARS-CoV-2 replication in human bronchial epithelial cells Sorio, C. Lotti, V. Merigo, F. Lagni, A. Di Clemente, A. Ligozzi, M. Bernardi, P. Rossini, G. Concia, E. Plebani, R. Romano, M. Sbarbati, A. Gibellini, D. J Cyst Fibros Posters European Cystic Fibrosis Society. 2022-10 2022-10-03 /pmc/articles/PMC9527880/ http://dx.doi.org/10.1016/S1569-1993(22)01129-8 Text en Copyright © 2022 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Posters Sorio, C. Lotti, V. Merigo, F. Lagni, A. Di Clemente, A. Ligozzi, M. Bernardi, P. Rossini, G. Concia, E. Plebani, R. Romano, M. Sbarbati, A. Gibellini, D. 439 Cystic fibrosis transmembrane conductance regulator impairment strongly decreases SARS-CoV-2 replication in human bronchial epithelial cells |
| title | 439 Cystic fibrosis transmembrane conductance regulator impairment strongly decreases SARS-CoV-2 replication in human bronchial epithelial cells |
| title_full | 439 Cystic fibrosis transmembrane conductance regulator impairment strongly decreases SARS-CoV-2 replication in human bronchial epithelial cells |
| title_fullStr | 439 Cystic fibrosis transmembrane conductance regulator impairment strongly decreases SARS-CoV-2 replication in human bronchial epithelial cells |
| title_full_unstemmed | 439 Cystic fibrosis transmembrane conductance regulator impairment strongly decreases SARS-CoV-2 replication in human bronchial epithelial cells |
| title_short | 439 Cystic fibrosis transmembrane conductance regulator impairment strongly decreases SARS-CoV-2 replication in human bronchial epithelial cells |
| title_sort | 439 cystic fibrosis transmembrane conductance regulator impairment strongly decreases sars-cov-2 replication in human bronchial epithelial cells |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527880/ http://dx.doi.org/10.1016/S1569-1993(22)01129-8 |
| work_keys_str_mv | AT sorioc 439cysticfibrosistransmembraneconductanceregulatorimpairmentstronglydecreasessarscov2replicationinhumanbronchialepithelialcells AT lottiv 439cysticfibrosistransmembraneconductanceregulatorimpairmentstronglydecreasessarscov2replicationinhumanbronchialepithelialcells AT merigof 439cysticfibrosistransmembraneconductanceregulatorimpairmentstronglydecreasessarscov2replicationinhumanbronchialepithelialcells AT lagnia 439cysticfibrosistransmembraneconductanceregulatorimpairmentstronglydecreasessarscov2replicationinhumanbronchialepithelialcells AT diclementea 439cysticfibrosistransmembraneconductanceregulatorimpairmentstronglydecreasessarscov2replicationinhumanbronchialepithelialcells AT ligozzim 439cysticfibrosistransmembraneconductanceregulatorimpairmentstronglydecreasessarscov2replicationinhumanbronchialepithelialcells AT bernardip 439cysticfibrosistransmembraneconductanceregulatorimpairmentstronglydecreasessarscov2replicationinhumanbronchialepithelialcells AT rossinig 439cysticfibrosistransmembraneconductanceregulatorimpairmentstronglydecreasessarscov2replicationinhumanbronchialepithelialcells AT conciae 439cysticfibrosistransmembraneconductanceregulatorimpairmentstronglydecreasessarscov2replicationinhumanbronchialepithelialcells AT plebanir 439cysticfibrosistransmembraneconductanceregulatorimpairmentstronglydecreasessarscov2replicationinhumanbronchialepithelialcells AT romanom 439cysticfibrosistransmembraneconductanceregulatorimpairmentstronglydecreasessarscov2replicationinhumanbronchialepithelialcells AT sbarbatia 439cysticfibrosistransmembraneconductanceregulatorimpairmentstronglydecreasessarscov2replicationinhumanbronchialepithelialcells AT gibellinid 439cysticfibrosistransmembraneconductanceregulatorimpairmentstronglydecreasessarscov2replicationinhumanbronchialepithelialcells |